KKH Advisors

This February, I’ll be at #LEAP25 in Riyadh, on-site with a number of our clients - and joining a global lineup of innovators, creators, and leaders shaping the future. LEAP is where big ideas meet action and industries take their next step forward. Don’t miss the opportunity to join us. Thanks to the LEAP team for inviting us to participate. Excited to see all the innovation happening in the Middle East. Secure your pass today and enjoy 50% off the current Delegate Pass price with this exclusive link: https://lnkd.in/d8agCAuB #tech #AI #VC #healthtech

Our CEO & Co-Founder Chris Benko spoke on a panel at Biotech Showcase during #JPM25 week in SF. Investing In the TechBio Space: A Huge Impact on Therapeutic Development & a Shorter Time Frame to Revenue. TechBio companies generate revenue by providing services that enable and enhance drug and diagnostic development. They are not hindered by the long approval process and potential failures of the drug development that biotech companies face. Panelists: Celestine “Cee Cee” Schnugg - Managing Partner, Boom Capital Brent Vaughan - CEO, Stealth TechBio Navjeewan Khosla - Partner, Novo Holdings Chris Benko - CEO, Koneksa Benjamin Vandendriessche - Chief Delivery Officer, Digital Medicine Society (DiMe) Michael Sarshad - Managing Director, Commercial Advisory, Syneos Health

Our President and COO Mohit Trikha was on an oncology panel at #BiotechShowcase during #JPM25 week: The Battle Against Cancer: The Armamentarium Keeps Expanding. The discussion focused on emerging and evolving directions in the development of cutting-edge breakthroughs for difficult to treat cancers. Moderator: Joel Sandler, Ph.D. - Associate Partner, Ipsos Advisory Healthcare Panelists: William Ho - CEO, IN8bio Mohit Trikha - President & COO, Kivu Bioscience Joshua Stopek - VP R&D, HistoSonics, Inc. Zhen Su, MD MBA - CEO, Marengo Therapeutics Pamela Munster - Founder, CSO & Director, Alessa Therapeutics, Inc.

Where’s the best place to catch up on the latest in brain-computer interfaces (#BCIs)? #Davos2025.    Our CEO and Founder, Thomas Oxley, will be speaking on three amazing panels this week to dive into the potential and impact of #neurotechnology.   If you’re attending, check out the session info below:    🧠 Brain Resilience Strategies that Address Emerging Global Challenges  Wednesday, January 22 | 4:00 p.m. - 5:30 p.m. CET Hosted by Davos Alzheimer's Collaborative, more info at: https://lnkd.in/dun6Ardh    🧠 "Health & AI” event in Davos  Thursday, Jan 23 | 11:40 a.m. – 12:10 p.m. CET  Hosted by EPFL, more info at: https://www.epfl.ch/en/    🧠 Panel: What Is Sci-Fi, What Is High-Tech?  Friday, January 24 | 9:00 a.m. to 9:45 a.m. CET Hosted by World Economic Forum, more info at: https://lnkd.in/ePB9vqWT #WEF25

Had a fantastic conversation with Ashley Zehnder, CEO of Fauna Bio, exploring their innovative approach of uncovering targets and drugs by studying diverse species. 🌿🔬 🎧 Dive into our insightful interview, available for free on various major streaming platforms. Tune in to discover the fascinating world of cross-species research! #AnimalKingdom #Biotech #Innovation

KKH Advisors is excited to support Investival Showcase in Miami, March 10-11. This cutting-edge platform connects innovators with investors and partners through exclusive 1:1 sessions. Building on a decade of European success, we're bringing this dynamic format stateside. Whether you're a start-up or seasoned investor, don't miss this opportunity to shape the future of healthcare innovation in vibrant Miami. 🌴🌴🌴 Register here: 👇👇 https://lnkd.in/ecD7Rfpw Use our discount code ‘KKH15’ for 15% discount off registration. More info on KKH Advisors: https://lnkd.in/epCph-2m See you all there!

Our CEO Rich Yang will be representing Biolinq at the World Economic Forum's Annual Meeting in Davos this week, Jan 20-24. #WEF25 Read his op-ed published by the World Economic Forum about how wearable biosensors are transforming #diabetes care: https://lnkd.in/ebyHRc6A

Pharmaceutical Executive covers the oncology panel at #JPM25 hosted by Endpoints News: J.P. Morgan held its 43rd Annual Healthcare Conference, January 13-16, 2025, in San Francisco, CA. Tuesday’s session ‘Priorities in #oncology R&D’ focused on the diverse directions of this sector of the industry amongst regulatory changes, existing and emerging innovations, and more. The panel participants included: Daniel Malarek, CEO of Foundation Medicine; Steve Hahn, CEO of Harbinger Health; Maha Katabi, PhD, CFA, general partner at Sofinnova Investments ; and Marjorie Green, svp, head of oncology and clinical development at Merck. John Carroll the founder & editor of Endpoints News was the moderator. https://lnkd.in/ezEJ8MvW

The World Economic Forum published an op-ed by our CEO & Founder Thomas Oxley, who will be speaking about #neurotech and #BCIs on a panel at #Davos2025, Jan 20-24. This year’s meeting convenes under the title “Collaboration for the Intelligent Age.” Session Title: What is Sci-Fi, What is High-Tech? 🧠🧠 Date: Friday, January 24, 9:00-9:45 am Moderator: Nita Farahany “By decoding brain signals, neural interfaces can restore function in ways previously deemed impossible. For instance, patients with paralysis can now control robotic arms or prosthetics through thought alone. These applications are not science fiction and are already a reality in clinical settings.” Read the op-ed: 👇👇 https://lnkd.in/es-PdUeR #BCI #neurotechnology #Davos2025 #WEF25

Top predictions from #JPM25: - China NewCo price tag for assets will continue to increase due to more demand from U.S. entities - Mega triple digit Series A funding rounds will continue - M&A will ramp up because pharma needs to fill patent cliff. Certain bankers are busy…(makes me miss being an M&A reporter sometimes and the rush of breaking a story). - 2025 will be year of #BCI and #xenotransplantation and #regenmed #iPSCs What was fun at #JPM25 - seeing the entrepreneurs and innovators we work with on the panels - and getting there on time! 🔥🔥 - feedback from the entrepreneurs, founders and CEOs we work with and how we helped them - having readers come up to me and say they’ve been following my newsfeed on LinkedIn and saying hi! 👋🏻👋🏻 - hanging out with former colleagues and journalists at networking events 🍻🍻 - Hannah Wastyk CEO at Interface Biosciences giving me home-made cookies. I really needed sustenence so thank you! 😂 - meeting familiar faces on the street or in the Hilton hotel lobby at Biotech Showcase. - walking around SF this year in the sun and not getting soaked by the rain. ☔️ - last but not least, seeing my friends on the Demy-Colton and EBD Group teams putting such a great Biotech Showcase together this year. Sara Jane Demy you and the team did it again! Linda Burke Lila Taylor Sara Pinto Brenna McCarthy Merced Great seeing you all!